Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Goldman Sachs Maintains Sell on Maxeon Solar Technologies, Raises Price Target to $9

Goldman Sachs Maintains Sell on Maxeon Solar Technologies, Raises Price Target to $9

Goldman Sachs analyst Brian Lee maintains Maxeon Solar Technologies (NASDAQ:MAXN) with a Sell and raises the price target from $8 to $9.

August 22, 2022

1 minute read

Goldman Sachs analyst Brian Lee maintains Maxeon Solar Technologies (NASDAQ:MAXN) with a Sell and raises the price target from $8 to $9.

Needham Maintains Buy on Blueprint Medicines, Lowers Price Target to $57

February 17, 7:12 AM

Needham analyst Ami Fadia maintains Blueprint Medicines (NASDAQ:BPMC) with a Buy and lowers the price target from $60 to $57.

August 26, 9:24 AM

Moderna Inc (NASDAQ: MRNA) has

March 30, 1:00 PM

MoffettNathanson upgraded its rating of American Tower (NYSE:AMT) to Outperform with a price target of $234.00, changing its…

April 22, 2:31 PM

Auto union leader Shawn Fain said pundits all bet that the union would lose at the VW plant in Tennessee. They were wrong.